What to Do When a GLP-1 Stops Working

What to do when hunger returns and weight loss stalls.

WEIGHT MANAGEMENT

Sarina Helton, FNP-C, MSN, CAE-OM

10/7/20268 min read

What to Do When a GLP-1 Stops Working

Is Your Medication No Longer Effective—or Have You Reached a Normal Weight-Loss Plateau?

You started a GLP-1 medication and initially felt a dramatic difference. Hunger decreased, portions became smaller, food was easier to manage, and your weight began to fall.

Then something changed.

The scale stopped moving. Hunger returned. “Food noise” became louder. Portions increased, or you began regaining weight despite continuing the medication.

It may feel as though your GLP-1 has stopped working, but several different situations can produce this experience. Some are expected parts of long-term weight management. Others indicate that the dose, medication, eating pattern, or overall treatment plan needs to be reassessed.

First: Has the Medication Truly Stopped Working?

A GLP-1 medication may still be providing benefits even when you are no longer losing weight.

Consider whether it is still helping you:

Feel full sooner
Remain satisfied longer after eating
Control portions
Reduce snacking
Manage cravings or food noise
Avoid weight regain
Maintain improvements in blood glucose or other metabolic measurements

If your weight is stable after substantial weight loss, the medication may be helping you maintain that lower weight. Maintenance is a meaningful treatment outcome—not evidence of failure.

What Is a Weight-Loss Plateau?

A plateau is a period during which your average weight remains relatively stable despite continuing your treatment plan.

Daily fluctuations are not a true plateau. Body weight can temporarily change because of:

Fluid retention
Constipation
Menstrual-cycle changes
Increased sodium or carbohydrate intake
Travel
Strength training
Inflammation
Food remaining in the digestive tract

A meaningful plateau generally involves several weeks without a downward trend—not a few disappointing weigh-ins.

Why Do Plateaus Happen?

Weight loss changes the body.

As body weight decreases:

A smaller body requires less energy.
Resting energy expenditure generally declines.
Everyday movement may decrease without you noticing.
Hunger signals may increase.
The difference between energy intake and energy use becomes smaller.
Previous food portions may now maintain weight rather than produce continued loss.

Eventually, intake and energy expenditure may reach a new balance. This can occur even when the medication remains active.

In the STEP 5 trial, average weight loss with semaglutide 2.4 mg gradually plateaued at approximately week 60. Participants maintained an average loss of approximately 15% through week 104 while treatment continued. The plateau did not mean the medication had become useless; it was helping maintain the weight already lost. Garvey et al., 2022

1. Confirm the Medication, Dose, and Schedule

Before concluding that a medication has failed, verify exactly what you are taking.

Review:

The medication name
The prescribed dose in milligrams
The product concentration
The volume or syringe units administered
How frequently it is taken
Whether any doses have been missed
How long you have taken the current dose
Whether the product has been stored correctly
Whether your medication source or pharmacy has changed

This is particularly important with multidose vials. Syringe units describe volume—not the number of milligrams administered. A change in concentration can cause someone to receive a different dose even when the syringe appears to be filled to the same line.

Do not increase the dose or syringe volume until the instructions have been verified with your prescriber or dispensing pharmacy.

2. Determine Whether You Are at a Therapeutic Dose

Starting doses are intended primarily to improve tolerability. They are not necessarily expected to provide the medication’s full weight-management effect.

If hunger has returned while you are still titrating, a clinician may determine that continued dose escalation is appropriate.

A higher dose is not automatically the solution when:

You are already at the maximum recommended dose.
You have significant nausea, vomiting, diarrhea, or constipation.
You cannot consume adequate nutrition or fluids.
You have little appetite but are not losing weight.
The treatment has produced no meaningful response despite an adequate trial.
Another medical issue may be contributing.

Dose decisions should be based on treatment response and tolerability—not simply on a desire to make the scale move faster.

3. Look for Treatment Interruptions

GLP-1 therapy may feel less effective after:

Frequently missed doses
Insurance-related interruptions
Medication shortages
Pausing treatment for a procedure or illness
Repeatedly stopping and restarting
Remaining at a reduced dose after side effects
Extending the interval between doses to reduce cost

Treatment interruptions can affect both appetite control and weight trajectory.

If several doses have been missed, contact your clinician before restarting. Returning immediately to a previous high dose may cause significant gastrointestinal side effects.

4. Reassess Hunger, Portions, and Food Noise

Try to identify what has actually changed.

Ask yourself:

Am I physically hungry more frequently?
Am I able to eat larger portions?
Am I thinking about food more often?
Have cravings returned?
Am I grazing throughout the day?
Am I eating because of hunger, habit, stress, or convenience?
Has the medication effect changed throughout the entire week or mainly before the next dose?

This information is more useful than simply reporting, “It stopped working.”

A symptom and appetite review can help distinguish reduced medication effects from changes in routine, stress, sleep, or food availability.

5. Review Calorie Creep Without Blame

Calorie intake can gradually increase even when food choices appear unchanged.

Common sources include:

Portions slowly becoming larger
More frequent snacks
Liquid calories
Alcohol
Coffee creamers
Sauces, dressings, and cooking oils
Nuts, cheese, and nut butters
Bites and tastes that are not counted as meals
Increased restaurant or takeout meals
Weekend eating that differs significantly from weekday eating

The purpose of reviewing intake is not to shame you or prescribe starvation. It is to identify small changes that may now be enough to maintain your lower body weight.

A short food record—sometimes only three to seven days—can reveal patterns that are difficult to recall accurately.

6. Make Sure You Are Eating Enough Structure

Paradoxically, eating very little early in the day can make appetite more difficult to manage later.

Some patients respond to reduced appetite by:

Skipping meals
Eating very little protein
Relying on small snack foods
Waiting until evening to eat
Becoming extremely hungry at night
Cycling between heavy restriction and overeating

A more structured approach may include:

Protein at each meal
Fiber-rich foods
Adequate fluids
Planned meals or snacks when needed
Eating slowly
Stopping at comfortable fullness
Avoiding prolonged restriction that triggers rebound eating

The goal is not to eliminate hunger completely. Some normal hunger is expected.

7. Protect Muscle and Increase Movement

After weight loss, the body requires fewer calories to maintain its new size. Loss of lean tissue can further reduce energy needs.

Helpful strategies may include:

Resistance training at least twice weekly when medically appropriate
Adequate dietary protein
Regular walking
Gradually increasing daily steps
Breaking up prolonged sitting
Maintaining sleep and recovery

Exercise should not be used as punishment for eating. It supports muscle preservation, physical function, metabolic health, and long-term weight maintenance.

8. Review Sleep, Stress, and Mental Health

Inadequate sleep and chronic stress can increase hunger, reduce activity, worsen cravings, and make planning more difficult.

Consider whether the plateau began around:

A new work schedule
Menopause-related sleep disruption
Increased caregiving responsibilities
Depression or anxiety
Relationship stress
Travel
Injury or illness
Reduced sleep
A major life transition

The medication may not have changed. The environment around it may have.

9. Review Other Medications and Medical Conditions

Some medications can promote weight gain, increase hunger, cause fatigue, or contribute to fluid retention. Examples include certain:

Antipsychotics
Antidepressants
Mood stabilizers
Corticosteroids
Insulins and insulin-stimulating medications
Seizure medications
Antihistamines
Hormonal treatments

Medical contributors may include:

Hypothyroidism
Type 2 diabetes
Sleep apnea
Polycystic ovary syndrome
Menopause-related body-composition changes
Reduced mobility
Fluid retention
Depression
Other endocrine disorders

Do not stop a necessary medication without guidance. A clinician can determine whether additional evaluation or a medically appropriate alternative should be considered.

10. Decide Whether the Goal Needs to Be Reassessed

A plateau does not always require another medication or a stricter diet.

Questions to consider include:

How much weight have I already lost?
Has my waist circumference decreased?
Have blood pressure, glucose, mobility, pain, or sleep improved?
Is my current weight maintainable?
Would pursuing additional loss require unsustainable restriction?
Is the goal based on health, function, or a number I feel obligated to reach?
Am I comparing myself with someone who started at a different weight or has a different medical history?

A clinically meaningful improvement may occur without reaching a “normal” BMI or a specific goal weight.

11. Consider Whether the Medication Should Be Changed

A medication change may be reasonable when:

You have had an adequate trial at an appropriate dose.
Appetite control has meaningfully diminished.
Weight regain continues despite consistent treatment.
Side effects prevent effective dosing.
You never achieved a clinically meaningful response.
Another medication is more appropriate for your medical history.
Cost or insurance coverage makes continued treatment impractical.

Potential options may include:

Adjusting the current dose when appropriate
Switching to a different incretin-based medication
Using a different FDA-approved weight-management medication
Considering combination pharmacotherapy
Addressing a contributing medication or health condition
Revising the nutrition or activity strategy
Evaluating eligibility for metabolic or bariatric surgery
Referring for additional nutritional, behavioral, or specialist support

Not every option is appropriate for every patient. Medication selection depends on health history, contraindications, pregnancy potential, blood pressure, psychiatric history, seizure risk, cardiovascular disease, diabetes, other medications, previous treatment response, insurance, and cost.

Should You Switch From Semaglutide to Tirzepatide?

Tirzepatide produces greater average weight loss than semaglutide in clinical trials, but a switch is not automatically the correct response to every plateau.

It may be reasonable to discuss when:

Semaglutide has been used consistently at an appropriate dose.
Additional weight loss is clinically indicated.
Hunger control has weakened substantially.
Semaglutide response has been limited.
Tirzepatide is medically appropriate and financially accessible.

Switching medications will not correct an incorrect dose, irregular use, untreated sleep apnea, a weight-promoting medication, or an eating pattern that has become unsustainable.

Has Your Body Become “Immune” to the Medication?

There is not strong evidence that the body simply becomes immune to GLP-1 medications in the way bacteria can become resistant to an antibiotic.

The initial dramatic sensation may become less noticeable over time. Gastrointestinal effects often decrease, and the medication may no longer feel as powerful as it did during the first few weeks.

That does not prove it has stopped working.

The more important questions are whether appetite regulation has changed, whether weight is being maintained, and what happens when treatment is interrupted.

Do Not Stop Solely Because Weight Loss Has Plateaued

Stopping treatment may allow appetite and weight-regulating biology to reassert themselves.

In the STEP 1 extension, participants regained approximately two-thirds of their prior weight loss during the year after semaglutide was discontinued. Wilding et al., 2022

Similarly, the STEP 4 trial found that people who continued semaglutide after the initial treatment period continued losing weight, while those switched to placebo regained weight. Rubino et al., 2021

This does not mean every person must remain on the same medication or dose forever. It means discontinuation should be planned rather than treated as proof that the underlying disease has disappeared.

What Not to Do When Progress Stops

Do not:

Increase the medication without guidance
Shorten the interval between injections
Combine two GLP-1 medications
Copy another patient’s syringe instructions
Respond by severely restricting food
Use vomiting or persistent nausea as evidence of effectiveness
Add unregulated weight-loss products
Stop necessary medications without consulting their prescriber
Assume the plateau represents a personal failure
Continue an ineffective and expensive treatment indefinitely without reassessment

When to Contact Your Clinician

Request a treatment review if:

Your average weight has not changed for several weeks or months.
You are regaining weight.
Hunger or food noise has substantially returned.
You are unsure of your dose or medication concentration.
You have missed or interrupted treatment.
Side effects prevent you from reaching an effective dose.
You are eating very little but are not losing weight.
You have developed swelling, unusual fatigue, or other new symptoms.
Your medication is no longer affordable.
You are considering switching or stopping treatment.

Bottom Line

When a GLP-1 appears to stop working, first determine whether you are experiencing:

A brief fluctuation
A normal weight-loss plateau
Successful weight maintenance
Reduced appetite control
Inconsistent medication exposure
An inadequate dose
Calorie creep or reduced activity
A new medication or health-related contributor
True inadequate treatment response

The solution is not always a higher dose, a different medication, or a more restrictive diet.

A thoughtful reassessment should determine what the medication is still accomplishing, what has changed, whether additional weight loss remains medically appropriate, and which next step is most likely to be safe and sustainable.

Ready to Start Your Weight Management Journey?

GLP-1 medications can be powerful tools, but the right medication, dose, and rate of dose escalation can be different for each person.

At Optima Vida Healthcare, weight management is individualized based on your health history, previous treatments, response to medication, side effects, goals, and long-term needs.

Treatment may include GLP-1 or other weight-management medications when medically appropriate, along with ongoing monitoring and support.

Start Your Weight Management Evaluation →

Or Visit www.ovhmed.com for more information.

Prescription medication is not guaranteed and is prescribed only when clinically appropriate after evaluation by a licensed healthcare provider.

Medical Disclaimer

This information is provided for general educational purposes only and is not a substitute for individualized medical advice, diagnosis, or treatment.

References

Garvey WT, Batterham RL, Bhatta M, et al. Two-Year Effects of Semaglutide in Adults with Overweight or Obesity: The STEP 5 Trial. Nat Med. 2022;28:2083–2091. https://doi.org/10.1038/s41591-022-02026-4

Wilding JPH, Batterham RL, Davies M, et al. Weight Regain and Cardiometabolic Effects After Withdrawal of Semaglutide: The STEP 1 Trial Extension. Diabetes Obes Metab. 2022;24:1553–1564. https://pubmed.ncbi.nlm.nih.gov/35441470/

Rubino D, Abrahamsson N, Davies M, et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA. 2021;325:1414–1425. https://pubmed.ncbi.nlm.nih.gov/33755728/

Aronne LJ, Sattar N, Horn DB, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial. JAMA. 2024;331:38–48. https://pubmed.ncbi.nlm.nih.gov/38078870/